These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22796182)

  • 1. Quinolylhydrazones as novel inhibitors of Plasmodium falciparum serine protease PfSUB1.
    Gemma S; Giovani S; Brindisi M; Tripaldi P; Brogi S; Savini L; Fiorini I; Novellino E; Butini S; Campiani G; Penzo M; Blackman MJ
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5317-21. PubMed ID: 22796182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design of the first difluorostatone-based PfSUB1 inhibitors.
    Giovani S; Penzo M; Brogi S; Brindisi M; Gemma S; Novellino E; Savini L; Blackman MJ; Campiani G; Butini S
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3582-6. PubMed ID: 24909083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Silico screening on the three-dimensional model of the Plasmodium vivax SUB1 protease leads to the validation of a novel anti-parasite compound.
    Bouillon A; Giganti D; Benedet C; Gorgette O; Pêtres S; Crublet E; Girard-Blanc C; Witkowski B; Ménard D; Nilges M; Mercereau-Puijalon O; Stoven V; Barale JC
    J Biol Chem; 2013 Jun; 288(25):18561-73. PubMed ID: 23653352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multifunctional serine protease primes the malaria parasite for red blood cell invasion.
    Koussis K; Withers-Martinez C; Yeoh S; Child M; Hackett F; Knuepfer E; Juliano L; Woehlbier U; Bujard H; Blackman MJ
    EMBO J; 2009 Mar; 28(6):725-35. PubMed ID: 19214190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate derived peptidic α-ketoamides as inhibitors of the malarial protease PfSUB1.
    Kher SS; Penzo M; Fulle S; Finn PW; Blackman MJ; Jirgensons A
    Bioorg Med Chem Lett; 2014 Sep; 24(18):4486-4489. PubMed ID: 25129616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtilisin-like Serine Protease 1 (SUB1) as an Emerging Antimalarial Drug Target: Current Achievements in Inhibitor Discovery.
    Lidumniece E; Withers-Martinez C; Hackett F; Blackman MJ; Jirgensons A
    J Med Chem; 2022 Oct; 65(19):12535-12545. PubMed ID: 36137276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidic boronic acids are potent cell-permeable inhibitors of the malaria parasite egress serine protease SUB1.
    Lidumniece E; Withers-Martinez C; Hackett F; Collins CR; Perrin AJ; Koussis K; Bisson C; Blackman MJ; Jirgensons A
    Proc Natl Acad Sci U S A; 2021 May; 118(20):. PubMed ID: 33975947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular discharge of a serine protease mediates release of invasive malaria parasites from host erythrocytes.
    Yeoh S; O'Donnell RA; Koussis K; Dluzewski AR; Ansell KH; Osborne SA; Hackett F; Withers-Martinez C; Mitchell GH; Bannister LH; Bryans JS; Kettleborough CA; Blackman MJ
    Cell; 2007 Dec; 131(6):1072-83. PubMed ID: 18083098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of proteases that regulate erythrocyte rupture by the malaria parasite Plasmodium falciparum.
    Arastu-Kapur S; Ponder EL; Fonović UP; Yeoh S; Yuan F; Fonović M; Grainger M; Phillips CI; Powers JC; Bogyo M
    Nat Chem Biol; 2008 Mar; 4(3):203-13. PubMed ID: 18246061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmepsins IX and X are essential and druggable mediators of malaria parasite egress and invasion.
    Nasamu AS; Glushakova S; Russo I; Vaupel B; Oksman A; Kim AS; Fremont DH; Tolia N; Beck JR; Meyers MJ; Niles JC; Zimmerberg J; Goldberg DE
    Science; 2017 Oct; 358(6362):518-522. PubMed ID: 29074774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and structure-activity relationship studies of 4-quinolinyl- and 9-acrydinylhydrazones as potent antimalarial agents.
    Fattorusso C; Campiani G; Kukreja G; Persico M; Butini S; Romano MP; Altarelli M; Ros S; Brindisi M; Savini L; Novellino E; Nacci V; Fattorusso E; Parapini S; Basilico N; Taramelli D; Yardley V; Croft S; Borriello M; Gemma S
    J Med Chem; 2008 Mar; 51(5):1333-43. PubMed ID: 18278859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KBE009: An antimalarial bestatin-like inhibitor of the Plasmodium falciparum M1 aminopeptidase discovered in an Ugi multicomponent reaction-derived peptidomimetic library.
    González-Bacerio J; Maluf SEC; Méndez Y; Pascual I; Florent I; Melo PMS; Budu A; Ferreira JC; Moreno E; Carmona AK; Rivera DG; Alonso Del Rivero M; Gazarini ML
    Bioorg Med Chem; 2017 Sep; 25(17):4628-4636. PubMed ID: 28728898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational reverse-engineering of a spider-venom derived peptide active against Plasmodium falciparum SUB1.
    Bastianelli G; Bouillon A; Nguyen C; Crublet E; Pêtres S; Gorgette O; Le-Nguyen D; Barale JC; Nilges M
    PLoS One; 2011; 6(7):e21812. PubMed ID: 21818266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium subtilisin-like protease 1 (SUB1): insights into the active-site structure, specificity and function of a pan-malaria drug target.
    Withers-Martinez C; Suarez C; Fulle S; Kher S; Penzo M; Ebejer JP; Koussis K; Hackett F; Jirgensons A; Finn P; Blackman MJ
    Int J Parasitol; 2012 May; 42(6):597-612. PubMed ID: 22543039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docking, synthesis and antimalarial activity of novel 4-anilinoquinoline derivatives.
    Vijayaraghavan S; Mahajan S
    Bioorg Med Chem Lett; 2017 Apr; 27(8):1693-1697. PubMed ID: 28318947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains.
    Gemma S; Kukreja G; Fattorusso C; Persico M; Romano MP; Altarelli M; Savini L; Campiani G; Fattorusso E; Basilico N; Taramelli D; Yardley V; Butini S
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5384-8. PubMed ID: 16890433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolytic activation of the essential parasitophorous vacuole cysteine protease SERA6 accompanies malaria parasite egress from its host erythrocyte.
    Ruecker A; Shea M; Hackett F; Suarez C; Hirst EM; Milutinovic K; Withers-Martinez C; Blackman MJ
    J Biol Chem; 2012 Nov; 287(45):37949-63. PubMed ID: 22984267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-functioning antimalarials that inhibit the chloroquine-resistance transporter.
    Egan TJ; Kuter D
    Future Microbiol; 2013 Apr; 8(4):475-89. PubMed ID: 23534360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facile synthesis and in-vitro antimalarial activity of novel α-hydroxy hydrazonates.
    Khankischpur M; Hansen FK; Meurer R; Mauz T; Bergmann B; Walter RD; Geffken D
    Arch Pharm (Weinheim); 2011 Nov; 344(11):755-64. PubMed ID: 21932256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ca(2+) -mediated exocytosis of subtilisin-like protease 1: a key step in egress of Plasmodium falciparum merozoites.
    Agarwal S; Singh MK; Garg S; Chitnis CE; Singh S
    Cell Microbiol; 2013 Jun; 15(6):910-21. PubMed ID: 23217145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.